Related Experiment Video
Updated: Oct 13, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
High prevalence of factor V Leiden mutation in mothers of premature neonates
E Erhardt1, J Stankovics, D Molnár
1Department of Paediatrics, University Medical School of Pécs, Hungary. erhardte@apacs.pote.hu
Insights
The Leiden mutation is more prevalent in mothers of premature infants (18%) than in those with growth-retarded neonates (7.2%). This finding suggests a potential link between the Leiden mutation and premature birth, warranting further investigation.
Area of Science:
- Medical Genetics
- Obstetrics and Gynecology
- Neonatology
Background:
- The Leiden mutation, a common genetic risk factor for thrombosis, is associated with adverse pregnancy outcomes.
- Premature birth and intrauterine growth retardation are significant neonatal health concerns with multifactorial causes.
Purpose of the Study:
- To investigate the prevalence of the Leiden mutation in mothers of premature infants and neonates with intrauterine growth retardation.
- To compare these prevalences with that of the general Hungarian population.
Main Methods:
- Genotyping for the Leiden mutation was performed on two groups of mothers: 50 mothers of premature infants and 56 mothers of intrauterine-growth-retarded neonates.
- Prevalence data were compared statistically with a control group of healthy Hungarian subjects.
Main Results:
- The prevalence of the Leiden mutation was 18% in mothers of premature infants.
- The prevalence was 7.2% in mothers of growth-retarded neonates.
- The prevalence in mothers of premature infants was significantly higher (p < 0.01) than in the healthy Hungarian population (6.3%).
Conclusions:
- The study suggests a potential, previously unrecognized association between the Leiden mutation and premature birth.
- Further research with larger cohorts is needed to confirm this relationship and elucidate its clinical significance.
Abstract:
The prevalence of the Leiden mutation was tested in 50 mothers of premature infants and in 56 mothers of intrauterine-growth-retarded neonates. The prevalence of the Leiden mutation was 7.2% in the mothers of growth-retarded neonates and 18% in the group of mothers of premature infants, the latter being significantly higher than the 6.3% prevalence of this mutation in healthy Hungarian subjects (p < 0.01). In spite of the relatively small number of mothers examined, the unexpected finding may call attention to a hitherto unknown relationship.
Related Concept Videos
Probability Laws
Development of the Oral Microbiota
Cytomegalovirus Disease
Mitral Valve Prolapse I: Introduction